HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates electroCore (NASDAQ:ECOR) with a Buy and raises the price target from $2.75 to $7.
ReShape Lifesciences Says Utilization Of Its Lap-Band Increased During COVID-19 Pandemic
ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight-loss solutions company, today announced that Lap-Band® utilization has increased since COVID-19 in response to patients' increased